Juliet Carrara

Juliet Carrara serves as the Vice President of Quality Assurance and Regulatory Affairs at Kryptos Biotechnologies, Inc., where operations focus on developing a rapid real-time reverse transcriptase (RT-PCR) in vitro diagnostic test system. With extensive experience in regulatory affairs and quality assurance, Juliet has held various leadership roles, including President of Carrara RA/QA Consulting since 2009, providing strategic guidance to medical device and diagnostic companies. Prior positions include Executive Vice President at Cytovale, Vice President at Genturadx, and Vice President at OptiScan Biomedical Corporation. Juliet's career also features significant roles at Inverness Medical Innovations, Cholestech Corp, and Bio-Rad Laboratories, contributing to the establishment and management of regulatory and quality functions across multiple sectors. Juliet holds an MBA from Saint Mary's College of California and a BA in Rhetoric and Health Sciences from the University of California, Berkeley.